Mediators and mechanisms of acute lung injury

被引:42
作者
Parsons, PE
机构
[1] Denver Hlth Med Ctr, Dept Med 4000, Med Intens Care Unit, Denver, CO 80204 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm & Crit Care Med, Denver, CO 80262 USA
关键词
D O I
10.1016/S0272-5231(05)70159-3
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
In the last decade since this topic was reviewed in this forum, there have been tremendous advances in the understanding of the basic mechanisms of the pathogenesis of acute lung injury (ALI). Translating this knowledge into understanding the development of acute respiratory distress syndrome (ARDS) in humans has been complex. To date, no single mediator or specific group of mediators has been shown to predict the development of ARDS, define ARDS, or be associated specifically and consistently with morbidity from the syndrome. Recently, however, several concepts-including the impact of patient heterogeneity in clinical studies, the potential importance of balance between pro- and anti-inflammatory mediators, and the potential contribution of genetic regulation in the development of ALI-have been introduced that likely will further our understanding of the development of ARDS in patients. One hopes that these concepts can be expanded so that, in the next decade, successful therapeutic interventions for the prevention and treatment of ARDS will become available.
引用
收藏
页码:467 / +
页数:11
相关论文
共 64 条
[1]
Relative production of tumour necrosis factor a and interleukin 10 in adult respiratory distress syndrome [J].
Armstrong, L ;
Millar, AB .
THORAX, 1997, 52 (05) :442-446
[2]
BACHOFEN M, 1982, CLIN CHEST MED, V3, P35
[3]
Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]
THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[5]
Adherence to endothelial cells induces release of soluble Tumor Necrosis Factor (TNF) receptor forms from neutrophil granulocytes [J].
Björnberg, F ;
Lantz, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 244 (02) :594-598
[6]
The role of nuclear factor-kappa B in cytokine gene regulation [J].
Blackwell, TS ;
Christman, JW .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) :3-9
[7]
THE PATHOGENESIS OF SEPSIS [J].
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) :457-469
[8]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[9]
PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME [J].
CASEY, LC ;
BALK, RA ;
BONE, RC .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) :771-778
[10]
HIGH-LEVELS OF INTERLEUKIN-8 IN THE BLOOD AND ALVEOLAR SPACES OF PATIENTS WITH PNEUMONIA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME [J].
CHOLLETMARTIN, S ;
MONTRAVERS, P ;
GIBERT, C ;
ELBIM, C ;
DESMONTS, JM ;
FAGON, JY ;
GOUGEROTPOCIDALO, MA .
INFECTION AND IMMUNITY, 1993, 61 (11) :4553-4559